Employers should keep in mind that indication-based coverage decisions (such as covering GLP-1 drugs for diabetes treatment but not for treatment of obesity or other conditions, such as addiction) can potentially raise concerns under the Americans with Disabilities Act (ADA), the ACA, HIPAAs nondiscrimination requirements, or the Mental Health Parity and Addiction Equity Act, among other laws
Anyone with severe abdominal pain, repeated vomiting, fainting, allergic symptoms, or signs of dehydration should seek medical care
[1] While most side effects of GLP-1 medications are mild and short lived, its important to know what youre getting into all the same
16 weeks 2 x 10 mL bottles 6 x 10 mg vials use 12.0 mL
It must complete Phase 3 trials and undergo FDA review before becoming available for prescription in Florida
Estimates range from 1560% across sources depending on measurement method and whether resistance training was involved